June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

April 18, 2017April 18, 2017

Study Finds Entrectinib Safe, Effective for Patients with Melanoma and Other Cancers

News

Ignyta’s candidate product entrectinib has shown promise as a treatment for several cancer types including melanoma, according to results of two Phase 1 clinical trials. Treatment with entrectinib was well-tolerated ... Read more

April 13, 2017

Combining IMO-2125 and Yervoy Shows Promise in Certain Metastatic Melanoma Patients

News

Combining Idera Pharmaceuticals‘ intratumoral IMO-2125 treatment with Yervoy (ipilimumab) may be a promising treatment approach for patients with metastatic melanoma who are refractory to anti-PD-1 therapies, according to preliminary data from ... Read more

April 11, 2017

Bacteria-derived Therapy AdVCA0848 Improves Survival in Mice with Melanoma, Study Indicates

News

A new therapy that activates a protein pathway to stifle melanoma tumor growth has shown promise as a treatment for the disease, a study reports. A single injection of the ... Read more

April 6, 2017

Opdivo, Yervoy Combo Improved Survival in Advanced Melanoma Phase 3 Trial

News

Opdivo (nivolumab) in combination with Yervoy (ipilimumab), as well as Opdivo alone, outperformed Yervoy monotherapy in terms of overall survival in a Phase 3 clinical trial of previously untreated patients ... Read more

April 4, 2017

Early-stage Eye Melanoma Trial Tests Less-invasive Treatment Approach

News

Patients with ocular melanoma, a type of melanoma that develops in the eye, have a potentially new and groundbreaking treatment option being assessed in a Phase 1 clinical trial. The ... Read more

March 30, 2017

Nanoparticles Carrying Anticancer Medication May Be New Weapon Against Melanoma

News

Researchers at the Penn State College of Medicine developed a novel drug to fight melanoma called CelePlum-777, a set of nanoparticles loaded with the anticancer drugs celecoxib and plumbagin, and that ... Read more

March 28, 2017March 28, 2017

Expert Panel Recommends National Guidelines to Improve Melanoma Screening

News

A group of experts have outlined recommendations for multiple melanoma screening to initiate the implementation of a national consensus on screening procedures. Currently there is no national screening guideline for melanoma, ... Read more

March 23, 2017March 23, 2017

DecisionDx-Melanoma Test Shows Promise in Predicting Distant Metastasis

News

Castle Biosciences‘ DecisionDx-Melanoma gene expression profile (GEP) test is a promising tool to identify melanoma patients at high risk of developing metastatic disease, according to recently presented data from five studies ... Read more

March 21, 2017March 21, 2017

Advanced Melanoma Patients with Initial BRAF Therapy Resistance Can Be Treated Again, Study Finds

News

People with advanced and metastatic melanoma who had become resistant to BRAF-targeted therapy were successfully retreated with this therapy after a three-month pause, researchers in Belgium reported. A liquid biopsy tool, Idylla ... Read more

March 16, 2017March 16, 2017

Not Enough Melanoma Survivors Limit Exposure to Sun or Protect Skin

News

While most melanoma survivors are more likely to limit their exposure to the sun and protect their skin than people who never had the disease, a considerable number still report getting ... Read more

March 14, 2017

Mutations in DNA Damage Repair Protein Suppress Immune System in Melanoma

News

Mutations in a protein involved in DNA damage repair may be key for melanomas to remain undetected by the immune system. Such mutations lead to the recruitment of pro-tumoral macrophages and ... Read more

March 9, 2017

Parkinson’s and Melanoma Link May Be Explained by ‘Red-Hair Gene’ Variant

News

Researchers have found that the melanocortin 1 receptor (MC1R) gene is needed to protect neurons from damaging toxins and for the production of dopamine in the brain, two characteristics that ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group